List view / Grid view

Giovanni Caforio

 

news

Giovanni Caforio, M.D., appointed Chief Operating Officer and elected to Board of Directors

Bristol-Myers Squibb Company (NYSE:BMY) today announced that Giovanni Caforio, M.D.,…

9 June 2014 | By

Bristol-Myers Squibb Company (NYSE:BMY) today announced that Giovanni Caforio, M.D., has been appointed chief operating officer and elected to Bristol-Myers Squibb’s Board of Directors, effective June 5, 2014. He will continue to report to Lamberto Andreotti, chief executive officer. In addition to his current responsibilities as chief commercial officer, Caforio…